Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001445064-14-000039
Filing Date
2014-09-08
Accepted
2014-09-08 18:47:01
Documents
1
Period of Report
2014-08-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 8794
  Complete submission text file 0001445064-14-000039.txt   10105
Mailing Address DAMASTOWN MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1300 N. KELLOGG DRIVE SUITE D ANAHEIM CA 92807
Business Address
Furey Raymond J. (Reporting) CIK: 0001577899 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35803 | Film No.: 141092014